Cargando…

New FDA Guidance on General Clinical Trial Conduct in the Era of COVID-19

Detalles Bibliográficos
Autor principal:	Turner, J. Rick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Editor Emeritus Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211045/ https://www.ncbi.nlm.nih.gov/pubmed/32557317 http://dx.doi.org/10.1007/s43441-020-00160-0

Ejemplares similares

Perspectives on the FDA Draft Guidances for Use of Adipose Tissue
por: Johnson, Martin L., et al.
Publicado: (2017)

FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology
por: Russell, Elizabeth S., et al.
Publicado: (2023)

Conducting a VR Clinical Trial in the Era of COVID-19
por: Stradford, Joy, et al.
Publicado: (2021)

Conducting a medical examination in the COVID-19 era: an Egyptian experience
por: Gado, Ahmed S., et al.
Publicado: (2021)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

Clinical and daily respiratory care and clinical trials within the COVID-19 era
por: Diamant, Zuzana, et al.
Publicado: (2020)

Waste in COVID-19 clinical trials conducted in western Europe
por: Dal-Ré, Rafael, et al.
Publicado: (2020)

Conducting Clinical Research in the Era of Covid-19
por: Perez, Tamra, et al.
Publicado: (2020)

A new era in Internet interventions: The advent of Chat-GPT and AI-assisted therapist guidance
por: Carlbring, Per, et al.
Publicado: (2023)

Understanding the new FDA pregnancy and lactation labeling rules()
por: Blattner, Collin M., et al.
Publicado: (2016)

Electrophysiology and COVID-19: An era of new potential
por: Gleva, Marye J.
Publicado: (2020)

Response to “Facial Line Outcomes (FLO-11) and Facial Line Satisfaction Questionnaire (FLSQ) Meet FDA PRO Guidance”
por: Ascher, Benjamin, et al.
Publicado: (2020)

Clinical trials and Consolidated Standards of Reporting Trials: Continuing concerns of compliance in COVID-19 era
por: Bhatt, Arun
Publicado: (2022)

Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel
por: Psotka, Mitchell A., et al.
Publicado: (2020)

Rediscovering FDA Websites
por: Navarro, Robert P.
Publicado: (2012)

Facial Line Outcomes (FLO-11) and Facial Line Satisfaction Questionnaire (FLSQ) Meet FDA Patient-Reported Outcome Guidance
por: Patel, Vaishali, et al.
Publicado: (2020)

Impact of non‐binding FDA guidances on primary endpoint selection in Alzheimer's disease trials
por: Yu, Jeffrey C., et al.
Publicado: (2022)

New challenges for lung transplantation in the era of COVID-19
por: Fernandes, Lucas Matos, et al.
Publicado: (2022)

Telemedicine in the COVID-19 era: the new normal
por: Kumar, Praveen, et al.
Publicado: (2020)

Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer’s disease
por: Harrison, John E.
Publicado: (2018)

Guidance for the Conduct and Reporting of Clinical Trials of Breast Milk Substitutes
por: Jarrold, Katharine, et al.
Publicado: (2020)

Tracheostomy in the COVID-19 era: global and multidisciplinary guidance
por: McGrath, Brendan A, et al.
Publicado: (2020)

COVID-19: where is the national ethical guidance?
por: Huxtable, Richard
Publicado: (2020)

Paxlovid(TM) Information From FDA and Guidance for AES Members
por: Cokley, Jon A., et al.
Publicado: (2022)

Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19
por: Oldenburg, Catherine E., et al.
Publicado: (2020)

A new kind of diabetes medication approved by the FDA: is there hope for obesity?
por: Dhirani, Danisha, et al.
Publicado: (2023)

Telemedicine in the Era of COVID-19 and Beyond: A new horizon
por: Alsaffar, Hussain, et al.
Publicado: (2020)

Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
por: Namiot, Eugenia D., et al.
Publicado: (2023)

Case Reports in the Era of Clinical Trials
por: Riley, David
Publicado: (2013)

COVID-19 pandemic: guidance for nuclear medicine departments
por: Paez, D., et al.
Publicado: (2020)

Clinical hypertension: a new era
por: Ha, Jong-Won
Publicado: (2014)

ESPEN expert statements and practical guidance on clinical nutrition in COVID-19 patients
por: Tan, Shanjun, et al.
Publicado: (2020)

The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
por: Arpinelli, Fabio, et al.
Publicado: (2006)

Sanitization of glaucoma clinic instruments in COVID-19 era
por: Parikh, Rajul S, et al.
Publicado: (2020)

Pattern of clinical research in the era of COVID-19 pandemic: A new learning experience for the present as well as future
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Thalamotomy for essential tremor: FDA approval brings brain treatment with FUS to the clinic
por: Fishman, Paul S.
Publicado: (2017)

Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?
por: Cooper, Lisa, et al.
Publicado: (2023)

Clinical movement disorders – a new era
por: Frucht, Steven J
Publicado: (2014)

Harmonizing the COVID-19 cacophony: People need guidance
por: Arif, Taha Bin, et al.
Publicado: (2020)

ERAS – The dawn of a new era!
por: Gopinath, Ramachandran, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6os6bp2o6ht99v22i4slcrn31h